233 related articles for article (PubMed ID: 34400274)
1. Progress in drug formulation design and delivery of medicinal substances used in ophthalmology.
Wróblewska KB; Jadach B; Muszalska-Kolos I
Int J Pharm; 2021 Sep; 607():121012. PubMed ID: 34400274
[TBL] [Abstract][Full Text] [Related]
2. Mechanistic modeling of ophthalmic drug delivery to the anterior chamber by eye drops and contact lenses.
Gause S; Hsu KH; Shafor C; Dixon P; Powell KC; Chauhan A
Adv Colloid Interface Sci; 2016 Jul; 233():139-154. PubMed ID: 26318359
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in ocular drug delivery.
Achouri D; Alhanout K; Piccerelle P; Andrieu V
Drug Dev Ind Pharm; 2013 Nov; 39(11):1599-617. PubMed ID: 23153114
[TBL] [Abstract][Full Text] [Related]
4. Ophthalmic drug dosage forms: characterisation and research methods.
Baranowski P; Karolewicz B; Gajda M; Pluta J
ScientificWorldJournal; 2014; 2014():861904. PubMed ID: 24772038
[TBL] [Abstract][Full Text] [Related]
5. State of the art clinical efficacy and safety evaluation of N-acetylcarnosine dipeptide ophthalmic prodrug. Principles for the delivery, self-bioactivation, molecular targets and interaction with a highly evolved histidyl-hydrazide structure in the treatment and therapeutic management of a group of sight-threatening eye diseases.
Babizhayev MA; Kasus-Jacobi A
Curr Clin Pharmacol; 2009 Jan; 4(1):4-37. PubMed ID: 19149498
[TBL] [Abstract][Full Text] [Related]
6. Drug delivery to the anterior segment of the eye: A review of current and future treatment strategies.
Mofidfar M; Abdi B; Ahadian S; Mostafavi E; Desai TA; Abbasi F; Sun Y; Manche EE; Ta CN; Flowers CW
Int J Pharm; 2021 Sep; 607():120924. PubMed ID: 34324989
[TBL] [Abstract][Full Text] [Related]
7. Topical ocular drug delivery systems: Innovations for an unmet need.
Yang Y; Lockwood A
Exp Eye Res; 2022 May; 218():109006. PubMed ID: 35248559
[TBL] [Abstract][Full Text] [Related]
8. [Ocular Drug Delivery System-based on Solid Nanoparticles].
Nagai N
Yakugaku Zasshi; 2021; 141(1):47-53. PubMed ID: 33390447
[TBL] [Abstract][Full Text] [Related]
9. Review of Approaches for Increasing Ophthalmic Bioavailability for Eye Drop Formulations.
Lanier OL; Manfre MG; Bailey C; Liu Z; Sparks Z; Kulkarni S; Chauhan A
AAPS PharmSciTech; 2021 Mar; 22(3):107. PubMed ID: 33719019
[TBL] [Abstract][Full Text] [Related]
10. Ocular preparations: the formulation approach.
Kaur IP; Kanwar M
Drug Dev Ind Pharm; 2002 May; 28(5):473-93. PubMed ID: 12098838
[TBL] [Abstract][Full Text] [Related]
11. Contact lenses as drug-delivery systems: a promising therapeutic tool.
Holgado MA; Anguiano-Domínguez A; Martín-Banderas L
Arch Soc Esp Oftalmol (Engl Ed); 2020 Jan; 95(1):24-33. PubMed ID: 31420118
[TBL] [Abstract][Full Text] [Related]
12. [Nanoparticles as drug delivery systems in ophthalmology].
Löscher M; Hurst J; Strudel L; Spitzer MS; Schnichels S
Ophthalmologe; 2018 Mar; 115(3):184-189. PubMed ID: 29110121
[TBL] [Abstract][Full Text] [Related]
13. Ophthalmic drug delivery systems--recent advances.
Bourlais CL; Acar L; Zia H; Sado PA; Needham T; Leverge R
Prog Retin Eye Res; 1998 Jan; 17(1):33-58. PubMed ID: 9537794
[TBL] [Abstract][Full Text] [Related]
14. Advances in ophthalmic drug delivery.
Morrison PW; Khutoryanskiy VV
Ther Deliv; 2014 Dec; 5(12):1297-315. PubMed ID: 25531930
[TBL] [Abstract][Full Text] [Related]
15. Polymeric hydrogels for novel contact lens-based ophthalmic drug delivery systems: a review.
Xinming L; Yingde C; Lloyd AW; Mikhalovsky SV; Sandeman SR; Howel CA; Liewen L
Cont Lens Anterior Eye; 2008 Apr; 31(2):57-64. PubMed ID: 17962066
[TBL] [Abstract][Full Text] [Related]
16. Glaucoma: Current treatment and impact of advanced drug delivery systems.
Yadav KS; Rajpurohit R; Sharma S
Life Sci; 2019 Mar; 221():362-376. PubMed ID: 30797820
[TBL] [Abstract][Full Text] [Related]
17. Recent patents and advances in ophthalmic drug delivery.
Janoria KG; Hariharan S; Dasari CR; Mitra AK
Recent Pat Drug Deliv Formul; 2007; 1(2):161-70. PubMed ID: 19075883
[TBL] [Abstract][Full Text] [Related]
18. Drug delivery by contact lens in spontaneously glaucomatous dogs.
Peng CC; Ben-Shlomo A; Mackay EO; Plummer CE; Chauhan A
Curr Eye Res; 2012 Mar; 37(3):204-11. PubMed ID: 22335807
[TBL] [Abstract][Full Text] [Related]
19. Review of the latest solutions in the use of contact lenses as controlled release systems for ophthalmic drugs.
Stiler-Wyszyńska S; Golba S; Jurek-Suliga J; Kuczkowski S
Polim Med; 2023; 53(1):47-58. PubMed ID: 36637332
[TBL] [Abstract][Full Text] [Related]
20. [Ways to improve ocular bioavailability for topical applications].
Sirbat D; Marchal-Heussler L; Hoffman M; Maincent P
J Fr Ophtalmol; 2000 May; 23(5):505-9; quiz 523. PubMed ID: 10844314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
